Answers are grounded in this paper and cite their sources.
Background Mobile health (mHealth) apps are increasingly incorporated into diabetes self-management education and support (DSMES) programs to improve access to behavioral and clinical support. Although digital DSMES interventions have demonstrated benefits for self-management and glycemic control, considerable variability exists in app use, and less is known about whether preintervention technology attitudes are associated with subsequent app use and related outcomes. Objective This study examined whether baseline technology attitudes are associated with app use and whether app use is associated with diabetes self-care and hemoglobin A1c (HbA1c) among adults participating in a digital DSMES intervention. Methods We conducted a secondary analysis of the Living Healthier with Diabetes randomized controlled trial (RCT) in Texas (2020-2022). The RCT included 3 study arms: virtual DSMES, smartphone app–based DSMES, and a combined intervention. Analyses were restricted to the 2 intervention arms with app access. Baseline technology attitude was assessed using a 4-item composite scale. App use was measured using 2 indices: a primary app use index derived from days per week, minutes per day, and overall 3-month usage, and a feature-use index summing use across 10 app functions. Outcomes included HbA1c and diabetes self-care. Multivariable linear regression and linear mixed-effects models were used to evaluate associations after adjustment for intervention arm, age, gender, past month financial situation, and baseline outcome values. Results Of the 189 participants enrolled in the primary trial, 129 randomized to the intervention arms with smartphone app access were included. Follow-up HbA1c and diabetes self-care data were available for 116 (89.9%) and 114 (88.4%) participants at 3 months and 117 (90.7%) and 116 (89.9%) participants at 6 months, respectively. More positive baseline technology attitudes were associated with greater app use at both 3 months (β=0.64, 95% CI 0.29 to 0.99; P<.001) and 6 months (β=0.78, 95% CI 0.39 to 1.17; P<.001) but were not associated with feature use. App use was not associated with HbA1c at 3 months but was associated with lower HbA1c at 6 months (β=−0.04, 95% CI −0.074 to −0.013; P=.005) and in longitudinal models (β=−0.04, 95% CI −0.074 to −0.006; P=.02). Greater app use was associated with higher self-care at 3 months (β=0.56, 95% CI 0.29 to 0.82; P<.001) and 6 months (β=0.38, 95% CI 0.14 to 0.62; P=.002) and remained associated with self-care in longitudinal analyses (β=0.44, 95% CI 0.21 to 0.68; P<.001). App and feature use did not change significantly between 3 and 6 months (P=.14 and P=.11, respectively). Conclusions These findings suggest that preintervention technology attitudes are associated with greater app use within digital DSMES programs and that greater use of the app may represent an important pathway linking mHealth interventions with behavioral and clinical outcomes in adults with type 2 diabetes. Trial Registration ClinicalTrials.gov NCT06370494; http://clinicaltrials.gov/ct2/show/NCT06370494
No takes yet. Share an insight, caveat, or question.
Oware et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: